AccessPak for HIV PEP Expanded with Kaletra and Angiotensin II
Determining the interaction of AccessPak for HIV PEP Expanded with Kaletra and Angiotensin II and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / lopinavir / ritonavir / tenofovir
Brand name: AccessPak for HIV PEP Expanded with Kaletra
Synonyms: n.a.
Generic Name: angiotensin II
Brand name: Giapreza
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- AccessPak for HIV PEP Expanded with Kaletra-Angiotensin II Acetate
- AccessPak for HIV PEP Expanded with Kaletra-Angiotensin ii Intravenous
- AccessPak for HIV PEP Expanded with Kaletra-Anidulafungin
- AccessPak for HIV PEP Expanded with Kaletra-Anidulafungin Intravenous
- AccessPak for HIV PEP Expanded with Kaletra-Animi-3
- AccessPak for HIV PEP Expanded with Kaletra-Animi-3 with Vitamin D
- Angiotensin II-AccessPak for HIV PEP Expanded with Viracept
- Angiotensin II-Accolate
- Angiotensin II-Accretropin
- Angiotensin II-Accucaine
- Angiotensin II-AccuHist Drops
- Angiotensin II-AccuHist PDX Drops